A number of factors both stimulating and inhibiting angiogenesis have been described. In the current work, we demonstrate that the angiogenic factor vascular endothelial growth factor (VEGF) activates mitogen-activated protein kinase (MAPK) as has been previously shown for basic fibroblast growth factor. The antiagiogenic factor 16-kDa N-terminal fragment of human prolactin inhibits activation of MAPK distal to autophosphorylation of the putative VEGF receptor, Flk-1, and phospholipase C-gamma. These data show that activation and inhibition of MAPK may play a central role in the control of angiogenesis
Therapeutic angiogenesis is likely to require the administration of factors that complement each oth...
The aim of this study was to determine whether the downregulation of endogenous Fes by siRNA in cult...
Vascular endothelial growth factor (VEGF) is a potent endothelial cell mitogen which mediates its ef...
International audienceA number of factors both stimulating and inhibiting angiogenesis have been des...
Signaling pathways mediating the antiangiogenic action of 16K human (h)PRL include inhibition of vas...
Angiogenesis, the process of development of a new microvasculature, is regulated by a balance of pos...
The 16-kDa N-terminal fragment of human prolactin (16K hPRL) is a potent antiangiogenic factor that ...
Signaling pathways engaged by angiogenic factors bFGF and VEGF in tumor angiogenesis are not fully u...
Angiogenesis, the formation of new blood vessels from existing vasculature, plays an essential role ...
AMP-activated protein kinase (AMPK), a serine/threonine protein kinase, is a potent regulator of cel...
A finely tuned balance of angiogenic inhibitors and inducers controls the activity of angiogenesis c...
Fine tuning of vascular endothelial growth factor (VEGF) signaling is critical in endo-thelial cell ...
16K hPRL, the antiangiogenic 16-kDa N-terminal fragment of human prolactin was shown to prevent tumo...
The formation of a new blood supply, angiogenesis, is an essential component of carcinogenesis and u...
Midkine (MDK) is a heparin-binding growth factor involved in growth, survival, migration, and differ...
Therapeutic angiogenesis is likely to require the administration of factors that complement each oth...
The aim of this study was to determine whether the downregulation of endogenous Fes by siRNA in cult...
Vascular endothelial growth factor (VEGF) is a potent endothelial cell mitogen which mediates its ef...
International audienceA number of factors both stimulating and inhibiting angiogenesis have been des...
Signaling pathways mediating the antiangiogenic action of 16K human (h)PRL include inhibition of vas...
Angiogenesis, the process of development of a new microvasculature, is regulated by a balance of pos...
The 16-kDa N-terminal fragment of human prolactin (16K hPRL) is a potent antiangiogenic factor that ...
Signaling pathways engaged by angiogenic factors bFGF and VEGF in tumor angiogenesis are not fully u...
Angiogenesis, the formation of new blood vessels from existing vasculature, plays an essential role ...
AMP-activated protein kinase (AMPK), a serine/threonine protein kinase, is a potent regulator of cel...
A finely tuned balance of angiogenic inhibitors and inducers controls the activity of angiogenesis c...
Fine tuning of vascular endothelial growth factor (VEGF) signaling is critical in endo-thelial cell ...
16K hPRL, the antiangiogenic 16-kDa N-terminal fragment of human prolactin was shown to prevent tumo...
The formation of a new blood supply, angiogenesis, is an essential component of carcinogenesis and u...
Midkine (MDK) is a heparin-binding growth factor involved in growth, survival, migration, and differ...
Therapeutic angiogenesis is likely to require the administration of factors that complement each oth...
The aim of this study was to determine whether the downregulation of endogenous Fes by siRNA in cult...
Vascular endothelial growth factor (VEGF) is a potent endothelial cell mitogen which mediates its ef...